Additional evidence suggests that Beclin1 reduction impairs phagocytosis in microglia, affects APP processing in neurons, and increases Aβ deposition and neurodegeneration in APP transgenic mouse model with AD [24]. Here, BECN1 is linked to Alzheimer disease.